Historical record - last NADAC publication: 6/21/2023
Product Information
QC ASPIRIN EC 325 MG TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0210 per EA under NDC 63868089810. Its NADAC has been published 427 times since Apr 29, 2015.
Strength
325 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868089810
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/21/2023
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
12/14/1992
Pharmacological Classes
Price Statistics
The NADAC for QC ASPIRIN EC 325 MG TABLET has been published 427 times since Apr 29, 2015, and over the history we have for it it has risen 55.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0210 per EA |
|---|---|
| All-time high | $0.0224 (Apr 12, 2023) |
| All-time low | $0.0128 (Dec 23, 2015) |
| Median price | $0.0151 |
| Average price | $0.0159 |
| Largest weekly change | +15.9% (Oct 17, 2018) |
| Weeks tracked | 427 |
| Tracking since | Apr 29, 2015 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC ASPIRIN EC 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QC ASPIRIN EC 325 MG TABLET, manufactured by Chain Drug Marketing Association, is $0.0210 per EA (NDC 63868089810), effective Jun 28, 2023.
How has the price of QC ASPIRIN EC 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for QC ASPIRIN EC 325 MG TABLET has risen 55.8%. It has been tracked across 427 weekly CMS publications since Apr 29, 2015.
What are the highest and lowest recorded NADAC prices for QC ASPIRIN EC 325 MG TABLET?
Since Apr 29, 2015, the NADAC for QC ASPIRIN EC 325 MG TABLET has ranged from a low of $0.0128 (Dec 23, 2015) to a high of $0.0224 (Apr 12, 2023), with a median of $0.0151 per EA.
Are there cheaper alternatives to QC ASPIRIN EC 325 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC ASPIRIN 325 MG TABLET, is $0.0121 per EA — about 42% below QC ASPIRIN EC 325 MG TABLET.
Who manufactures QC ASPIRIN EC 325 MG TABLET?
QC ASPIRIN EC 325 MG TABLET (NDC 63868089810) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification